Common Stock Purchase Warrant Sample Contracts

Bio-Path Holdings Inc – SERIES a COMMON STOCK PURCHASE WARRANT Bio-Path Holdings, Inc. (January 22nd, 2019)

THIS SERIES A COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time following the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on ______________ (the "Termination Date") but not thereafter, to subscribe for and purchase from Bio-Path Holdings, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common stock (the "Common Stock"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

StemCells, Inc. – PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Microbot Medical Inc. (January 17th, 2019)

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six-month anniversary of the date hereof (the "Initial Exercise Date") and until on or prior to 5:00 p.m. (New York City time) on ______________1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain engagement letter, dated as of October 12, 2018, by and between the Company and H.C. Wainwright & Co., LLC.

Helios & Matheson North America Inc. – SERIES D COMMON STOCK PURCHASE WARRANT Helios and Matheson Analytics Inc. (January 16th, 2019)

THIS SERIES D COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after July 16, 2019 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on July 16, 2020 (the "Termination Date") but not thereafter, to subscribe for and purchase from Helios and Matheson Analytics Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common stock (the "Common Stock"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Bio-Path Holdings Inc – UNDERWRITER COMMON STOCK PURCHASE WARRANT Bio-Path Holdings, Inc. (January 16th, 2019)

THIS UNDERWRITER COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time following the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on January 14, 2024 (the "Termination Date") but not thereafter, to subscribe for and purchase from Bio-Path Holdings, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common stock (the "Common Stock"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Underwriting Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of January 14, 2019.

Helios & Matheson North America Inc. – SERIES C COMMON STOCK PURCHASE WARRANT Helios and Matheson Analytics Inc. (January 16th, 2019)

THIS SERIES C COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after July 16, 2019 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on July 16, 2024 (the "Termination Date") but not thereafter, to subscribe for and purchase from Helios and Matheson Analytics Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common stock (the "Common Stock"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Helios & Matheson North America Inc. – SERIES E COMMON STOCK PURCHASE WARRANT Helios and Matheson Analytics Inc. (January 16th, 2019)

THIS SERIES E COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after July 16, 2019 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on July 16, 2020 (the "Termination Date") but not thereafter, to subscribe for and purchase from Helios and Matheson Analytics Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common stock (the "Common Stock"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

StemCells, Inc. – PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Microbot Medical Inc. (January 16th, 2019)

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six-month anniversary of the date hereof (the "Initial Exercise Date") and until on or prior to 5:00 p.m. (New York City time) on ______________1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain engagement letter, dated as of October 12, 2018, by and between the Company and H.C. Wainwright & Co., LLC.

Helios & Matheson North America Inc. – Placement Agent Common Stock Purchase Warrant (January 16th, 2019)

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after July 16, 2019 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on January 15, 2024 (the "Termination Date") but not thereafter, to subscribe for and purchase from Helios and Matheson Analytics Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common stock (the "Common Stock"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of December 16, 2018.

Sysorex Global Holdings Corp. – Common Stock Purchase Warrant Inpixon (January 15th, 2019)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on [_____]1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Inpixon, a Nevada corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Warrant, subject to a Holder's right to elect to recei

Galectin Therapeutics Inc. – Second Amendment to Common Stock Purchase Warrant (January 15th, 2019)
LandStar, Inc. – Common Stock Purchase Warrant Landstar, Inc. (January 11th, 2019)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, the person more particularly descried on Exhibit "A", attached hereto and incorporated herein by reference (the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (as defined above) and on or prior to the close of business on the fifth (5th) anniversary of the Issue Date (the "Termination Date") but not thereafter, to subscribe for and purchase from LANDSTAR, INC., a Nevada corporation (the "Company"), up to ___________________ shares (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b), subject to adjustment herein. This Warrant is issued by the Company as of the Is

Newmarkt Corp. – Common Stock Purchase Warrant Ozop Surgical Corp. (January 11th, 2019)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the issuance of the $150,000.00 senior convertible promissory note to the Holder (as defined below) of even date) (the "Note"), Auctus Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Ozop Surgical Corp., a Nevada corporation (the "Company"), up to 50,000 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated January 7, 2019, by and among the Company

Future Healthcare of America – COMMON STOCK PURCHASE WARRANT Future Healthcare of America (January 11th, 2019)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, Alpha Capital Anstalt or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [the effective date of the Registration Statement (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on October 18, 2021 (the "Termination Date") but not thereafter, to subscribe for and purchase from Future Healthcare of America, a Wyoming corporation (the "Company"), up to 33,000,000 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON STOCK PURCHASE WARRANT Magnegas APPLIED TECHNOLOGY SOLUTIONS, INC. (January 11th, 2019)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, [_______________________]., a [____] corporation or assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, on the Initial Exercise Date (as defined below) and on or prior to the close of business on the date that is forty-two (42) months from the Closing Date (the "Termination Date") but not thereafter, to subscribe for and purchase from MagneGas Applied Technology Solutions, Inc., a Delaware corporation (the "Company"), up to [ ] shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common stock, par value $0.001 per share (the "Common Stock"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 1(b).

Future Healthcare of America – COMMON STOCK PURCHASE WARRANT Future Healthcare of America (January 11th, 2019)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, Alpha Capital Anstalt or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the effective date of the Registration Statement (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on November 13, 2022 (the "Termination Date") but not thereafter, to subscribe for and purchase from Future Healthcare of America, a Wyoming corporation (the "Company"), up to 6,000,000 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sysorex Global Holdings Corp. – Common Stock Purchase Warrant Inpixon (January 8th, 2019)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on [_____]1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Inpixon, a Nevada corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Warrant, subject to a Holder's right to elect to recei

Original Source Entertainment, Inc. – NeuroOne Medical Technologies Corporation [Form Of] Common Stock Purchase Warrant (January 4th, 2019)

This Warrant is issued in connection with the Company's private placement solely to accredited investors of units, each consisting of 1 share of the Company's common stock, par value $0.001 per share (the "Common Stock"), and a warrant to purchase 1 share of Common Stock, (the "Private Placement"), which may be issued in one or more closings, in accordance with, and subject to, the terms and conditions described in the Subscription Agreement, dated as of even date herewith (the "Subscription Agreement"). Capitalized terms used and not otherwise defined herein shall have the respective meanings assigned to such terms in the Subscription Agreement.

Galectin Therapeutics Inc. – First Amendment to Common Stock Purchase Warrant (January 3rd, 2019)
Innovus Pharmaceuticals, Inc. – Series [A/B/C Prefunded] Common Stock Purchase Warrant (December 31st, 2018)

THIS SERIES [A/B/C PREFUNDED] COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") [and on or prior to 5:00 p.m. (New York City time) on eighteen (18) month anniversary of the Reverse Stock Split Date]1 [and on or prior to 5:00 p.m. (New York City time) on five and a half (5.5) year anniversary of the Reverse Stock Split Date]2 [and until this Warrant is exercised in full]3 (the "Termination Date") but not thereafter, to subscribe for and purchase from Innovus Pharmaceuticals, Inc., a Nevada corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Sec

Aurora Creative Group – COMMON STOCK PURCHASE WARRANT AGEAGLE Aerial Systems Inc. (December 28th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, Alpha Capital Anstalt or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on December 26, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from AgEagle Aerial Systems Inc., a Nevada corporation (the "Company"), up to 3,703,703 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

GeoVax – Series H Common Stock Purchase Warrant (December 28th, 2018)

THIS SERIES H COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, Sabby Healthcare Master Fund, Ltd or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June 27, 2019 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on the 30 month anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from GeoVax Labs, Inc., a Delaware corporation (the "Company"), up to _________________ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Cerecor Inc. – Common Stock Purchase Warrant Cerecor Inc. (December 27th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, Armistice Capital Master Fund Ltd or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date set forth above (the Initial Exercise Date) and on or prior to the close of business on the five year and six month anniversary of the Initial Exercise Date (the Termination Date) but not thereafter, to subscribe for and purchase from Cerecor Inc., a Delaware corporation (the Company), up to 4,000,000 shares (as subject to adjustment hereunder, the Warrant Shares) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Nemaura Medical Inc. – Common Stock Purchase Warrant Nemaura Medical Inc. (December 26th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, CEDE & CO. or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on December 20, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Nemaura Medical Inc., a Nevada corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Warrant, subject to a Holder's righ

Common Stock Purchase Warrant Mannkind Corporation (December 21st, 2018)
Alliance MMA, Inc. – Common Stock Purchase Warrant (December 19th, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, SCWorx Acquisition corp. or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Issuance Date"), subject to receipt of the Exchange Approval (as defined in the Purchase Agreement), and on or prior to the close of business on the five (5)-year anniversary of the Issuance Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Alliance MMA, Inc., a Delaware corporation (the "Company"), up to 343,750 shares (as subject to adjustment hereunder, the "Warrant Shares") of common stock, par value $0.001 per share, of the Company (the "Common Stock"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Purchase Agreement (as define

Alliance MMA, Inc. – Common Stock Purchase Warrant (December 19th, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, [ ] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date the Company's shareholders have approved the execution of the Purchase Agreement and the transactions contemplated therein as required by the Purchase Agreement and shall have received the approval of Nasdaq with respect to the Purchase Agreement and the issuance of the shares of Common Stock contemplated therein (the "Approval Date"), subject to receipt of the Exchange Approval (as defined in the Purchase Agreement), and on or prior to the close of business on the five (5)-year anniversary of the Approval Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Alliance MMA, Inc., a Delaware corporation (the "Company"), up to [ ] shares (as subject to adjustment hereunder, the "Warrant Shares")

Capnia, Inc. – Common Stock Purchase Warrant Soleno Therapeutics, Inc. (December 19th, 2018)
Skyline Medical Inc. – Common Stock Purchase Warrant Precision Therapeutics Inc. (December 19th, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, the Holder (as defined below), Dawson James Securities, Inc., a Florida corporation (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October 1, 2018 ("Issuance Date"), to purchase from Precision Therapeutics Inc., a Delaware corporation (the "Company"), up to 53,589 shares of Common Stock (as defined below) (the "Warrant Shares") at the Exercise Price (defined below) per share then in effect.

Neurotrope, Inc. – Series G Common Stock Purchase Warrant Neurotrope, Inc. (December 17th, 2018)

THIS SERIES G COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, ________________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June [ ], 2019 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on June [ ], 20241 (the "Termination Date") but not thereafter, to subscribe for and purchase from Neurotrope, Inc., a Nevada corporation (the "Company"), up to ________________ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sport Endurance, Inc. – Common Stock Purchase Warrant (December 13th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, ___________________________, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the two (2) year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Sport Endurance, Inc., a Nevada corporation (the "Company"), up to _______ shares of Common Stock (subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Underwriter Common Stock Purchase Warrant Tenax Therapeutics, Inc. (December 11th, 2018)

THIS UNDERWRITER COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on December 7, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Tenax Therapeutics, Inc., a Delaware corporation (the "Company"), up to 207,253 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued by the Company as of the date hereof pursuant to Section 2.3(iv) of the Underwriting Agreement, dated as of December 7, 2018 (the "Underwriting Agreement"), between the Company and Ladenburg Thalmann & Co. Inc. ("Ladenb

Avista Healthcare Public Acquisition Corp. – ORGANOGENESIS, INC. Common Stock Purchase Warrant (December 11th, 2018)

This Warrant is one of the Stock Purchase Warrants (the Warrants) evidencing the right to purchase shares of Common Stock of the Company, issued pursuant to a certain Note and Warrant Purchase Agreement (the Agreement), dated as of November 3, 2010, between the Company and the Persons listed in the Schedule of Purchasers attached thereto, a copy of which is on file at the principal office of the Company and the holder of this Warrant shall be entitled to all of the benefits of the Agreement, as provided therein.

Subscription Agreement for Shares of Common Stock and Common Stock Purchase Warrants (December 11th, 2018)

This SUBSCRIPTION Agreement (this "Agreement") is made as of September 21, 2018 by, and between MYnd Analytics, Inc., a Delaware corporation (the "Company"), and the investors listed on Schedule A hereto (each, an "Investor," and collectively, the "Investors").

Series [1][2] Common Stock Purchase Warrant Tenax Therapeutics, Inc. (December 11th, 2018)

THIS SERIES [1] [2] COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on _____1 2 (the "Termination Date") but not thereafter, to subscribe for and purchase from Tenax Therapeutics, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Warrant, subject to

Praco – Common Stock Purchase Warrant Arista Financial Corp. (December 10th, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the funding of purchase price of $36,500.00, for the first tranche of $40,500.00 under the $121,500.00 convertible promissory note issued to the Holder (as defined below) on December 3, 2018) (the "Note"), Crown Bridge Partners, LLC (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Arista Financial Corp., a Nevada corporation (the "Company"), 20,250 shares of Common Stock (as defined below) (the "Warrant Shares") at the Exercise Price per share then in effect (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant).